The agreement with The Cube Group provides technical pedigree from core Solana developers.
Friday’s trading session brought a surprise to the financial market as Mangoceuticals, the men’s health and wellness company, announced an aggressive diversification into the blockchain sector. Through its subsidiary Mango DAT, LLC, the company confirmed that Mangoceuticals adopts Solana treasury strategy with an ambitious plan of up to $100 million.
This aggressive maneuver seeks to transform the firm’s corporate balance sheet, using the SOL token as the primary reserve asset under the framework known as “MULTI-DAT.”
To ensure institutional-grade execution, the company formed an alliance with The Cube Group, a team with a proven track record in the development of the Solana ecosystem.
At the core of this initiative — beyond asset accumulation — is the generation of non-dilutive yields. The strategy targets a base staking yield of between 7% and 8%, with the potential to reach annualized returns of up to 20% through active management in decentralized finance (DeFi) protocols.
Jacob Cohen, CEO of the firm, noted that the fact that Mangoceuticals adopts Solana treasury strategy allows NASDAQ investors to gain unique and productive exposure to one of the most scalable networks in the world.
Unlike the MicroStrategy model, which focuses on Bitcoin as a static store of value, Mangoceuticals focuses on the interest-generating properties of Solana. However, the funding of the plan through “at-the-market” (ATM) stock offering programs has sparked some caution.
While this movement generated technological optimism, MGRX shares experienced high volatility, trading at $1.05 with a drop of nearly 20% following the announcement. This behavior reflects the market’s duality regarding small-cap companies seeking cash flow efficiency through crypto assets.
With this decision, it is clear that Mangoceuticals adopts Solana treasury strategy not just as an investment, but as a paradigm shift in its corporate structure facing the new digital economy.
